It can be seen that regardless of the subgroup, VHL has the highest mutation rate of more than 40% in ccRCC, followed by PBRM1, TTN, SETD2, etc. (Figures 8A,B). This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.